Efficacy of a Single Dose of Albendazole for Treating Ascaris lumbricoides in Schoolchildren in Northwest Ethiopia: An Open-Label Trial Examining Re-Infection Rates and Contributing Factors - Top-Institutions - DentalSpire

Efficacy of a Single Dose of Albendazole for Treating Ascaris lumbricoides in Schoolchildren in Northwest Ethiopia: An Open-Label Trial Examining Re-Infection Rates and Contributing Factors

  • By

  • Hana Misganaw

  • Mebratu Tamir

  • Yalewayker Tegegne

  • Zufan Yiheyis Abriham

  • Dereje Mengesha Berta

  • Bisrat Birke Teketelew

  • Negesse Cherie

  • Tsedenya Gebeyehu

  • Elias Chane

  • Abiy Ayele Angelo

  • Aberham Abere

  • Abebaw Setegn

  • Tegegne Eshetu

  • January 30, 2026

  • 0 min

Share

Top Institutions in Dental

Brief introduction explaining scope and methodology.

  • #1

    London School of Hygiene & Tropical Medicine
    London School of Hygiene & Tropical Medicine

    London, N/A

    Key Differentiators

    • Infectious Diseases
    • Parasitology
    • Global Health

  • #2

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Parasitology
    • Public Health

  • #3

    Ifakara Health Institute
    Ifakara Health Institute

    Ifakara, Tanzania

    Key Differentiators

    • Infectious Diseases
    • Parasitology
    • Epidemiology

  • #4

    Addis Ababa University, College of Health Sciences
    Addis Ababa University, College of Health Sciences

    Addis Ababa, Ethiopia

    Key Differentiators

    • Parasitology
    • Infectious Diseases
    • Public Health

  • #5

    University of Washington, Department of Global Health
    University of Washington, Department of Global Health

    Seattle, WA

    Key Differentiators

    • Global Health
    • Infectious Diseases
    • Parasitology

Original Source(s)

Efficacy of a Single Dose of Albendazole for Treating Ascaris lumbricoides in Schoolchildren in Northwest Ethiopia: An Open-Label Trial Examining Re-Infection Rates and Contributing Factors

  • by Hana Misganaw, Mebratu Tamir, Yalewayker Tegegne, Zufan Yiheyis Abriham, Dereje Mengesha Berta, Bisrat Birke Teketelew, Negesse Cherie, Tsedenya Gebeyehu, Elias Chane, Abiy Ayele Angelo, Aberham Abere, Abebaw Setegn, Tegegne Eshetu

  • January 30, 2026

Related Content

Toothbrush Contamination May Be Common, Awareness Low

A study links poor toothbrush hygiene habits to bacterial growth and limited patient knowledge.

Medical Oddities: Chew on This Cancer Prevention Idea

From gum to gut to memory—medicine gets weirdly clever fast 

Glucocorticoids as adjunctive therapy for severe myelosuppression induced by combined immune checkpoint inhibitor and chemotherapy: a case report and literature review